nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SCN11A—melanoma	0.542	0.726	CbGaD
Procainamide—SCN10A—melanoma	0.204	0.273	CbGaD
Procainamide—SLC22A5—Dactinomycin—melanoma	0.0441	0.735	CbGbCtD
Procainamide—CYP2D6—Vemurafenib—melanoma	0.0159	0.265	CbGbCtD
Procainamide—Lucanthone—APEX1—melanoma	0.00212	0.265	CrCbGaD
Procainamide—Vasculitis—Vemurafenib—melanoma	0.00141	0.0262	CcSEcCtD
Procainamide—Drug fever—Docetaxel—melanoma	0.0014	0.026	CcSEcCtD
Procainamide—Lupus erythematosus—Docetaxel—melanoma	0.00125	0.0233	CcSEcCtD
Procainamide—Rash maculo-papular—Vemurafenib—melanoma	0.00125	0.0232	CcSEcCtD
Procainamide—Hepatomegaly—Dactinomycin—melanoma	0.0011	0.0204	CcSEcCtD
Procainamide—Atrial fibrillation—Vemurafenib—melanoma	0.00105	0.0196	CcSEcCtD
Procainamide—Arthritis—Vemurafenib—melanoma	0.00103	0.0191	CcSEcCtD
Procainamide—Eosinophilia—Vemurafenib—melanoma	0.000854	0.0159	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Docetaxel—melanoma	0.000844	0.0157	CcSEcCtD
Procainamide—Hepatic enzyme increased—Temozolomide—melanoma	0.000743	0.0138	CcSEcCtD
Procainamide—Supraventricular tachycardia—Docetaxel—melanoma	0.000713	0.0133	CcSEcCtD
Procainamide—Benzocaine—SCN11A—melanoma	0.000699	0.0874	CrCbGaD
Procainamide—Cardiac disorder—Vemurafenib—melanoma	0.000641	0.0119	CcSEcCtD
Procainamide—Hepatic failure—Dactinomycin—melanoma	0.000627	0.0117	CcSEcCtD
Procainamide—Arthritis—Bleomycin—melanoma	0.000622	0.0116	CcSEcCtD
Procainamide—Chills—Vemurafenib—melanoma	0.000619	0.0115	CcSEcCtD
Procainamide—Pleural effusion—Docetaxel—melanoma	0.00061	0.0113	CcSEcCtD
Procainamide—Dysgeusia—Vemurafenib—melanoma	0.000589	0.0109	CcSEcCtD
Procainamide—Lethargy—Dactinomycin—melanoma	0.000575	0.0107	CcSEcCtD
Procainamide—Hepatic failure—Temozolomide—melanoma	0.000567	0.0106	CcSEcCtD
Procainamide—Sunitinib—MAP2K2—melanoma	0.000524	0.0654	CrCbGaD
Procainamide—Myalgia—Vemurafenib—melanoma	0.000512	0.00952	CcSEcCtD
Procainamide—Arthralgia—Vemurafenib—melanoma	0.000512	0.00952	CcSEcCtD
Procainamide—Oliguria—Docetaxel—melanoma	0.000507	0.00943	CcSEcCtD
Procainamide—Hypotension—Vemurafenib—melanoma	0.000458	0.00853	CcSEcCtD
Procainamide—Neutropenia—Dactinomycin—melanoma	0.000456	0.00848	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000447	0.00831	CcSEcCtD
Procainamide—Neutropenia—Carmustine—melanoma	0.000427	0.00793	CcSEcCtD
Procainamide—Decreased appetite—Vemurafenib—melanoma	0.000426	0.00793	CcSEcCtD
Procainamide—Lightheadedness—Docetaxel—melanoma	0.000418	0.00778	CcSEcCtD
Procainamide—Neutropenia—Temozolomide—melanoma	0.000412	0.00767	CcSEcCtD
Procainamide—Proparacaine—SCN10A—melanoma	0.000409	0.051	CrCbGaD
Procainamide—Depression—Carmustine—melanoma	0.000406	0.00754	CcSEcCtD
Procainamide—Agranulocytosis—Dactinomycin—melanoma	0.000406	0.00754	CcSEcCtD
Procainamide—Renal failure—Carmustine—melanoma	0.0004	0.00744	CcSEcCtD
Procainamide—Sunitinib—PTK2B—melanoma	0.000397	0.0496	CrCbGaD
Procainamide—Sunitinib—MAP2K1—melanoma	0.000397	0.0496	CrCbGaD
Procainamide—Depression—Temozolomide—melanoma	0.000392	0.00729	CcSEcCtD
Procainamide—Flushing—Bleomycin—melanoma	0.000388	0.00722	CcSEcCtD
Procainamide—Body temperature increased—Vemurafenib—melanoma	0.000388	0.00721	CcSEcCtD
Procainamide—Hepatic failure—Docetaxel—melanoma	0.000377	0.00702	CcSEcCtD
Procainamide—Chills—Bleomycin—melanoma	0.000375	0.00698	CcSEcCtD
Procainamide—Oxybuprocaine—SCN10A—melanoma	0.000374	0.0467	CrCbGaD
Procainamide—Hallucination—Carmustine—melanoma	0.000363	0.00676	CcSEcCtD
Procainamide—Flushing—Dactinomycin—melanoma	0.000362	0.00673	CcSEcCtD
Procainamide—Hypersensitivity—Vemurafenib—melanoma	0.000361	0.00672	CcSEcCtD
Procainamide—Atrial fibrillation—Docetaxel—melanoma	0.000358	0.00666	CcSEcCtD
Procainamide—Renal impairment—Docetaxel—melanoma	0.000356	0.00663	CcSEcCtD
Procainamide—Asthenia—Vemurafenib—melanoma	0.000352	0.00655	CcSEcCtD
Procainamide—Hallucination—Temozolomide—melanoma	0.000351	0.00653	CcSEcCtD
Procainamide—Chills—Dactinomycin—melanoma	0.00035	0.00651	CcSEcCtD
Procainamide—Cardiac failure—Docetaxel—melanoma	0.000348	0.00646	CcSEcCtD
Procainamide—Chloroprocaine—SCN10A—melanoma	0.000347	0.0434	CrCbGaD
Procainamide—Pruritus—Vemurafenib—melanoma	0.000347	0.00645	CcSEcCtD
Procainamide—Lethargy—Docetaxel—melanoma	0.000346	0.00644	CcSEcCtD
Procainamide—Flushing—Carmustine—melanoma	0.000339	0.0063	CcSEcCtD
Procainamide—Ill-defined disorder—Bleomycin—melanoma	0.000338	0.00628	CcSEcCtD
Procainamide—Diarrhoea—Vemurafenib—melanoma	0.000336	0.00624	CcSEcCtD
Procainamide—Procaine—SCN10A—melanoma	0.000331	0.0414	CrCbGaD
Procainamide—Cinchocaine—SCN10A—melanoma	0.000331	0.0414	CrCbGaD
Procainamide—Malaise—Bleomycin—melanoma	0.000328	0.00611	CcSEcCtD
Procainamide—Cardiac disorder—Temozolomide—melanoma	0.000327	0.00609	CcSEcCtD
Procainamide—Flushing—Temozolomide—melanoma	0.000327	0.00609	CcSEcCtD
Procainamide—Dizziness—Vemurafenib—melanoma	0.000324	0.00603	CcSEcCtD
Procainamide—Chills—Temozolomide—melanoma	0.000317	0.00589	CcSEcCtD
Procainamide—Ill-defined disorder—Dactinomycin—melanoma	0.000315	0.00586	CcSEcCtD
Procainamide—Vomiting—Vemurafenib—melanoma	0.000312	0.0058	CcSEcCtD
Procainamide—Myalgia—Bleomycin—melanoma	0.00031	0.00577	CcSEcCtD
Procainamide—Abdominal pain upper—Docetaxel—melanoma	0.00031	0.00576	CcSEcCtD
Procainamide—Discomfort—Bleomycin—melanoma	0.000306	0.0057	CcSEcCtD
Procainamide—Malaise—Dactinomycin—melanoma	0.000306	0.0057	CcSEcCtD
Procainamide—Dysgeusia—Temozolomide—melanoma	0.000301	0.00559	CcSEcCtD
Procainamide—Confusional state—Bleomycin—melanoma	0.0003	0.00557	CcSEcCtD
Procainamide—Metoclopramide—CYP17A1—melanoma	0.000298	0.0372	CrCbGaD
Procainamide—Nausea—Vemurafenib—melanoma	0.000291	0.00542	CcSEcCtD
Procainamide—Thrombocytopenia—Bleomycin—melanoma	0.000291	0.00541	CcSEcCtD
Procainamide—Myalgia—Dactinomycin—melanoma	0.000289	0.00538	CcSEcCtD
Procainamide—Discomfort—Dactinomycin—melanoma	0.000286	0.00531	CcSEcCtD
Procainamide—Ill-defined disorder—Temozolomide—melanoma	0.000285	0.0053	CcSEcCtD
Procainamide—Anorexia—Bleomycin—melanoma	0.000283	0.00527	CcSEcCtD
Procainamide—Sunitinib—FLT1—melanoma	0.000283	0.0353	CrCbGaD
Procainamide—Angioedema—Temozolomide—melanoma	0.000281	0.00522	CcSEcCtD
Procainamide—Hypotension—Bleomycin—melanoma	0.000278	0.00517	CcSEcCtD
Procainamide—Malaise—Temozolomide—melanoma	0.000277	0.00515	CcSEcCtD
Procainamide—Convulsion—Carmustine—melanoma	0.000275	0.00512	CcSEcCtD
Procainamide—Neutropenia—Docetaxel—melanoma	0.000274	0.0051	CcSEcCtD
Procainamide—Thrombocytopenia—Dactinomycin—melanoma	0.000271	0.00505	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000271	0.00504	CcSEcCtD
Procainamide—Myalgia—Carmustine—melanoma	0.000271	0.00503	CcSEcCtD
Procainamide—Convulsion—Temozolomide—melanoma	0.000266	0.00495	CcSEcCtD
Procainamide—Anorexia—Dactinomycin—melanoma	0.000264	0.00491	CcSEcCtD
Procainamide—Benzocaine—SCN10A—melanoma	0.000263	0.0329	CrCbGaD
Procainamide—Confusional state—Carmustine—melanoma	0.000262	0.00487	CcSEcCtD
Procainamide—Myalgia—Temozolomide—melanoma	0.000261	0.00486	CcSEcCtD
Procainamide—Arthralgia—Temozolomide—melanoma	0.000261	0.00486	CcSEcCtD
Procainamide—Discomfort—Temozolomide—melanoma	0.000258	0.00481	CcSEcCtD
Procainamide—Decreased appetite—Bleomycin—melanoma	0.000258	0.00481	CcSEcCtD
Procainamide—Renal failure—Docetaxel—melanoma	0.000257	0.00478	CcSEcCtD
Procainamide—Thrombocytopenia—Carmustine—melanoma	0.000254	0.00472	CcSEcCtD
Procainamide—Confusional state—Temozolomide—melanoma	0.000253	0.0047	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000252	0.0047	CcSEcCtD
Procainamide—Anorexia—Carmustine—melanoma	0.000247	0.0046	CcSEcCtD
Procainamide—Thrombocytopenia—Temozolomide—melanoma	0.000245	0.00457	CcSEcCtD
Procainamide—Feeling abnormal—Bleomycin—melanoma	0.000245	0.00456	CcSEcCtD
Procainamide—Agranulocytosis—Docetaxel—melanoma	0.000244	0.00454	CcSEcCtD
Procainamide—Hypotension—Carmustine—melanoma	0.000242	0.00451	CcSEcCtD
Procainamide—Decreased appetite—Dactinomycin—melanoma	0.000241	0.00448	CcSEcCtD
Procainamide—Anorexia—Temozolomide—melanoma	0.000239	0.00444	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Carmustine—melanoma	0.000236	0.0044	CcSEcCtD
Procainamide—Urticaria—Bleomycin—melanoma	0.000236	0.00439	CcSEcCtD
Procainamide—Body temperature increased—Bleomycin—melanoma	0.000235	0.00437	CcSEcCtD
Procainamide—Feeling abnormal—Dactinomycin—melanoma	0.000228	0.00425	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000228	0.00425	CcSEcCtD
Procainamide—Sunitinib—PDGFRA—melanoma	0.000228	0.0285	CrCbGaD
Procainamide—Gastrointestinal pain—Dactinomycin—melanoma	0.000227	0.00422	CcSEcCtD
Procainamide—Decreased appetite—Carmustine—melanoma	0.000225	0.00419	CcSEcCtD
Procainamide—Body temperature increased—Dactinomycin—melanoma	0.000219	0.00408	CcSEcCtD
Procainamide—Abdominal pain—Dactinomycin—melanoma	0.000219	0.00408	CcSEcCtD
Procainamide—Hypersensitivity—Bleomycin—melanoma	0.000219	0.00407	CcSEcCtD
Procainamide—Decreased appetite—Temozolomide—melanoma	0.000218	0.00405	CcSEcCtD
Procainamide—Flushing—Docetaxel—melanoma	0.000218	0.00405	CcSEcCtD
Procainamide—Cardiac disorder—Docetaxel—melanoma	0.000218	0.00405	CcSEcCtD
Procainamide—Lidocaine—SCN10A—melanoma	0.000215	0.0268	CrCbGaD
Procainamide—Feeling abnormal—Carmustine—melanoma	0.000214	0.00398	CcSEcCtD
Procainamide—Asthenia—Bleomycin—melanoma	0.000213	0.00397	CcSEcCtD
Procainamide—Gastrointestinal pain—Carmustine—melanoma	0.000212	0.00395	CcSEcCtD
Procainamide—Chills—Docetaxel—melanoma	0.000211	0.00392	CcSEcCtD
Procainamide—Pruritus—Bleomycin—melanoma	0.00021	0.00391	CcSEcCtD
Procainamide—Feeling abnormal—Temozolomide—melanoma	0.000207	0.00384	CcSEcCtD
Procainamide—Abdominal pain—Carmustine—melanoma	0.000205	0.00381	CcSEcCtD
Procainamide—Body temperature increased—Carmustine—melanoma	0.000205	0.00381	CcSEcCtD
Procainamide—Gastrointestinal pain—Temozolomide—melanoma	0.000205	0.00381	CcSEcCtD
Procainamide—Hypersensitivity—Dactinomycin—melanoma	0.000204	0.0038	CcSEcCtD
Procainamide—Dysgeusia—Docetaxel—melanoma	0.0002	0.00372	CcSEcCtD
Procainamide—Urticaria—Temozolomide—melanoma	0.000199	0.0037	CcSEcCtD
Procainamide—Asthenia—Dactinomycin—melanoma	0.000199	0.0037	CcSEcCtD
Procainamide—Body temperature increased—Temozolomide—melanoma	0.000198	0.00369	CcSEcCtD
Procainamide—Abdominal pain—Temozolomide—melanoma	0.000198	0.00369	CcSEcCtD
Procainamide—Hypersensitivity—Carmustine—melanoma	0.000191	0.00355	CcSEcCtD
Procainamide—Diarrhoea—Dactinomycin—melanoma	0.00019	0.00353	CcSEcCtD
Procainamide—Vomiting—Bleomycin—melanoma	0.000189	0.00351	CcSEcCtD
Procainamide—Asthenia—Carmustine—melanoma	0.000186	0.00346	CcSEcCtD
Procainamide—Hypersensitivity—Temozolomide—melanoma	0.000185	0.00344	CcSEcCtD
Procainamide—Asthenia—Temozolomide—melanoma	0.00018	0.00335	CcSEcCtD
Procainamide—Diarrhoea—Carmustine—melanoma	0.000177	0.0033	CcSEcCtD
Procainamide—Pruritus—Temozolomide—melanoma	0.000177	0.0033	CcSEcCtD
Procainamide—Sunitinib—KDR—melanoma	0.000177	0.0221	CrCbGaD
Procainamide—Convulsion—Docetaxel—melanoma	0.000177	0.00329	CcSEcCtD
Procainamide—Nausea—Bleomycin—melanoma	0.000177	0.00328	CcSEcCtD
Procainamide—Vomiting—Dactinomycin—melanoma	0.000176	0.00328	CcSEcCtD
Procainamide—Arthralgia—Docetaxel—melanoma	0.000174	0.00323	CcSEcCtD
Procainamide—Myalgia—Docetaxel—melanoma	0.000174	0.00323	CcSEcCtD
Procainamide—Dizziness—Carmustine—melanoma	0.000172	0.00319	CcSEcCtD
Procainamide—Diarrhoea—Temozolomide—melanoma	0.000172	0.00319	CcSEcCtD
Procainamide—Confusional state—Docetaxel—melanoma	0.000168	0.00313	CcSEcCtD
Procainamide—Sunitinib—KIT—melanoma	0.000167	0.0209	CrCbGaD
Procainamide—Dizziness—Temozolomide—melanoma	0.000166	0.00308	CcSEcCtD
Procainamide—Vomiting—Carmustine—melanoma	0.000165	0.00307	CcSEcCtD
Procainamide—Nausea—Dactinomycin—melanoma	0.000165	0.00306	CcSEcCtD
Procainamide—Shock—Docetaxel—melanoma	0.000164	0.00305	CcSEcCtD
Procainamide—Thrombocytopenia—Docetaxel—melanoma	0.000163	0.00304	CcSEcCtD
Procainamide—Vomiting—Temozolomide—melanoma	0.000159	0.00296	CcSEcCtD
Procainamide—Anorexia—Docetaxel—melanoma	0.000159	0.00296	CcSEcCtD
Procainamide—Hypotension—Docetaxel—melanoma	0.000156	0.0029	CcSEcCtD
Procainamide—Lidocaine—EGFR—melanoma	0.000155	0.0193	CrCbGaD
Procainamide—Nausea—Carmustine—melanoma	0.000154	0.00287	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000152	0.00283	CcSEcCtD
Procainamide—Nausea—Temozolomide—melanoma	0.000149	0.00277	CcSEcCtD
Procainamide—Decreased appetite—Docetaxel—melanoma	0.000145	0.0027	CcSEcCtD
Procainamide—Feeling abnormal—Docetaxel—melanoma	0.000137	0.00256	CcSEcCtD
Procainamide—Gastrointestinal pain—Docetaxel—melanoma	0.000136	0.00254	CcSEcCtD
Procainamide—Body temperature increased—Docetaxel—melanoma	0.000132	0.00245	CcSEcCtD
Procainamide—Abdominal pain—Docetaxel—melanoma	0.000132	0.00245	CcSEcCtD
Procainamide—Hypersensitivity—Docetaxel—melanoma	0.000123	0.00228	CcSEcCtD
Procainamide—Asthenia—Docetaxel—melanoma	0.00012	0.00222	CcSEcCtD
Procainamide—Pruritus—Docetaxel—melanoma	0.000118	0.00219	CcSEcCtD
Procainamide—Diarrhoea—Docetaxel—melanoma	0.000114	0.00212	CcSEcCtD
Procainamide—Dizziness—Docetaxel—melanoma	0.00011	0.00205	CcSEcCtD
Procainamide—Vomiting—Docetaxel—melanoma	0.000106	0.00197	CcSEcCtD
Procainamide—Nausea—Docetaxel—melanoma	9.9e-05	0.00184	CcSEcCtD
Procainamide—Benzocaine—ABCB1—melanoma	5.78e-05	0.00722	CrCbGaD
Procainamide—Probenecid—ALB—melanoma	5.13e-05	0.00641	CrCbGaD
Procainamide—Probenecid—ABCB1—melanoma	4.9e-05	0.00612	CrCbGaD
Procainamide—Aminohippurate—ABCB1—melanoma	4.83e-05	0.00604	CrCbGaD
Procainamide—Lidocaine—ABCB1—melanoma	4.71e-05	0.00588	CrCbGaD
Procainamide—Sunitinib—ABCB1—melanoma	3.85e-05	0.00481	CrCbGaD
Procainamide—DNMT1—retina—melanoma	2.22e-05	0.0647	CbGeAlD
Procainamide—DNMT1—skin of body—melanoma	1.95e-05	0.0568	CbGeAlD
Procainamide—SCN11A—head—melanoma	1.95e-05	0.0568	CbGeAlD
Procainamide—SLC22A4—neck—melanoma	1.87e-05	0.0544	CbGeAlD
Procainamide—DNMT1—mammalian vulva—melanoma	1.78e-05	0.0518	CbGeAlD
Procainamide—SCN7A—head—melanoma	1.66e-05	0.0483	CbGeAlD
Procainamide—SCN8A—head—melanoma	1.48e-05	0.043	CbGeAlD
Procainamide—DNMT1—head—melanoma	1.27e-05	0.0371	CbGeAlD
Procainamide—SCN7A—lymph node—melanoma	1.16e-05	0.0338	CbGeAlD
Procainamide—SCN4A—head—melanoma	1.16e-05	0.0337	CbGeAlD
Procainamide—SCN1A—head—melanoma	1.12e-05	0.0325	CbGeAlD
Procainamide—SCN2A—head—melanoma	1.02e-05	0.0299	CbGeAlD
Procainamide—SLC22A3—mammalian vulva—melanoma	1e-05	0.0292	CbGeAlD
Procainamide—SCN10A—head—melanoma	9.87e-06	0.0288	CbGeAlD
Procainamide—SLC22A5—retina—melanoma	9.1e-06	0.0265	CbGeAlD
Procainamide—SCN9A—lymph node—melanoma	9.08e-06	0.0265	CbGeAlD
Procainamide—CHRM2—Signaling by GPCR—GNAQ—melanoma	9.03e-06	6.86e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNA11—melanoma	9.01e-06	6.84e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1B1—melanoma	9e-06	6.84e-05	CbGpPWpGaD
Procainamide—SCN3A—head—melanoma	9e-06	0.0262	CbGeAlD
Procainamide—SCN5A—Developmental Biology—KRAS—melanoma	9e-06	6.83e-05	CbGpPWpGaD
Procainamide—SCN5A—head—melanoma	8.97e-06	0.0262	CbGeAlD
Procainamide—DNMT1—lymph node—melanoma	8.91e-06	0.026	CbGeAlD
Procainamide—CHRM2—Signaling Pathways—GRM1—melanoma	8.9e-06	6.76e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR7—melanoma	8.9e-06	6.76e-05	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—melanoma	8.89e-06	6.75e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—FASN—melanoma	8.82e-06	6.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC6A11—melanoma	8.72e-06	6.62e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIP4K2A—melanoma	8.72e-06	6.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SUFU—melanoma	8.68e-06	6.59e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC5A5—melanoma	8.67e-06	6.59e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PRKCA—melanoma	8.67e-06	6.58e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ERCC2—melanoma	8.6e-06	6.53e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP17A1—melanoma	8.52e-06	6.47e-05	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MAPK1—melanoma	8.48e-06	6.44e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTAP—melanoma	8.48e-06	6.44e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—melanoma	8.47e-06	6.43e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNAQ—melanoma	8.38e-06	6.36e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CD44—melanoma	8.38e-06	6.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT3—melanoma	8.33e-06	6.33e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.2e-06	6.23e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—melanoma	8.2e-06	6.23e-05	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—melanoma	8.18e-06	6.21e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.13e-06	6.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RHOB—melanoma	8.1e-06	6.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BCL2L11—melanoma	8.1e-06	6.15e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNA11—melanoma	8.05e-06	6.11e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1B1—melanoma	8.03e-06	6.1e-05	CbGpPWpGaD
Procainamide—SLC22A5—skin of body—melanoma	7.99e-06	0.0233	CbGeAlD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.95e-06	6.03e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP17A1—melanoma	7.94e-06	6.03e-05	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	7.89e-06	5.99e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—FASN—melanoma	7.88e-06	5.98e-05	CbGpPWpGaD
Procainamide—BCHE—skin of body—melanoma	7.78e-06	0.0227	CbGeAlD
Procainamide—CHRM2—Signaling Pathways—HDAC6—melanoma	7.78e-06	5.91e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC5A5—melanoma	7.75e-06	5.88e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—EDN1—melanoma	7.71e-06	5.86e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—melanoma	7.65e-06	5.81e-05	CbGpPWpGaD
Procainamide—CHRM2—head—melanoma	7.64e-06	0.0223	CbGeAlD
Procainamide—ACHE—Metabolism of proteins—CXCL8—melanoma	7.64e-06	5.8e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LUM—melanoma	7.56e-06	5.74e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PHGDH—melanoma	7.56e-06	5.74e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CSF2—melanoma	7.54e-06	5.72e-05	CbGpPWpGaD
Procainamide—SLC22A1—head—melanoma	7.5e-06	0.0219	CbGeAlD
Procainamide—SLC22A1—Metabolism—GNA11—melanoma	7.5e-06	5.7e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CD44—melanoma	7.48e-06	5.68e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNAQ—melanoma	7.48e-06	5.68e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HPSE—melanoma	7.42e-06	5.63e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCB1—melanoma	7.41e-06	5.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCR2—melanoma	7.38e-06	5.6e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—melanoma	7.37e-06	5.6e-05	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	7.35e-06	5.59e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—FASN—melanoma	7.34e-06	5.58e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—melanoma	7.32e-06	5.56e-05	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—melanoma	7.31e-06	5.55e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CUBN—melanoma	7.28e-06	5.53e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RAC2—melanoma	7.26e-06	5.51e-05	CbGpPWpGaD
Procainamide—ACHE—lymph node—melanoma	7.24e-06	0.0211	CbGeAlD
Procainamide—CHRM2—GPCR downstream signaling—PRKCA—melanoma	7.23e-06	5.49e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC5A5—melanoma	7.22e-06	5.48e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1B1—melanoma	7.17e-06	5.45e-05	CbGpPWpGaD
Procainamide—SLC22A3—head—melanoma	7.17e-06	0.0209	CbGeAlD
Procainamide—CHRM2—Signaling Pathways—WNT5A—melanoma	7.15e-06	5.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFC—melanoma	7.15e-06	5.43e-05	CbGpPWpGaD
Procainamide—BCHE—mammalian vulva—melanoma	7.1e-06	0.0207	CbGeAlD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.09e-06	5.38e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—melanoma	7.04e-06	5.35e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SDHD—melanoma	7.03e-06	5.34e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CSPG4—melanoma	7.03e-06	5.34e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BSG—melanoma	7.03e-06	5.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDN1—melanoma	7e-06	5.32e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNAQ—melanoma	6.97e-06	5.3e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CD44—melanoma	6.97e-06	5.3e-05	CbGpPWpGaD
Procainamide—SCN10A—lymph node—melanoma	6.91e-06	0.0202	CbGeAlD
Procainamide—CHRM2—Signaling by GPCR—CSF2—melanoma	6.84e-06	5.2e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PRKCA—melanoma	6.82e-06	5.18e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—melanoma	6.81e-06	5.17e-05	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—melanoma	6.81e-06	5.17e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPAM—melanoma	6.81e-06	5.17e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CG—melanoma	6.79e-06	5.16e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ERCC2—melanoma	6.77e-06	5.14e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—melanoma	6.75e-06	5.13e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RAC1—melanoma	6.7e-06	5.09e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1B1—melanoma	6.69e-06	5.08e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCB1—melanoma	6.61e-06	5.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCA—melanoma	6.56e-06	4.98e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—melanoma	6.55e-06	4.98e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAP2K2—melanoma	6.41e-06	4.87e-05	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—melanoma	6.37e-06	4.84e-05	CbGpPWpGaD
Procainamide—SCN3A—lymph node—melanoma	6.3e-06	0.0184	CbGeAlD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—melanoma	6.28e-06	4.77e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2R—melanoma	6.27e-06	4.76e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PRKCA—melanoma	6.09e-06	4.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RAC1—melanoma	6.08e-06	4.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRB—melanoma	6.08e-06	4.61e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ERCC2—melanoma	6.04e-06	4.59e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CD—melanoma	5.97e-06	4.53e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCB1—melanoma	5.91e-06	4.49e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTK2B—melanoma	5.9e-06	4.48e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—melanoma	5.89e-06	4.47e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G6—melanoma	5.79e-06	4.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNA11—melanoma	5.74e-06	4.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GAB2—melanoma	5.74e-06	4.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FLT1—melanoma	5.71e-06	4.34e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CG—melanoma	5.66e-06	4.3e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.61e-06	4.26e-05	CbGpPWpGaD
Procainamide—SLC22A4—lymph node—melanoma	5.52e-06	0.0161	CbGeAlD
Procainamide—SLC22A1—Metabolism—ABCB1—melanoma	5.51e-06	4.18e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PRKCA—melanoma	5.44e-06	4.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FOXO4—melanoma	5.39e-06	4.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HDAC2—melanoma	5.39e-06	4.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCR4—melanoma	5.39e-06	4.1e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ERCC2—melanoma	5.39e-06	4.1e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CG—melanoma	5.34e-06	4.06e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAQ—melanoma	5.33e-06	4.05e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CB—melanoma	5.2e-06	3.95e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—VCAN—melanoma	5.2e-06	3.95e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—melanoma	5.16e-06	3.92e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—melanoma	5.15e-06	3.91e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CG—melanoma	5.14e-06	3.9e-05	CbGpPWpGaD
Procainamide—BCHE—head—melanoma	5.08e-06	0.0148	CbGeAlD
Procainamide—SLC22A1—Metabolism—PRKCA—melanoma	5.07e-06	3.85e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ERCC2—melanoma	5.03e-06	3.82e-05	CbGpPWpGaD
Procainamide—SLC22A3—lymph node—melanoma	5.02e-06	0.0146	CbGeAlD
Procainamide—CHRM2—Signaling Pathways—SYK—melanoma	5.02e-06	3.81e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5e-06	3.8e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	4.97e-06	3.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT3—melanoma	4.92e-06	3.74e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGFR—melanoma	4.92e-06	3.74e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ITGAV—melanoma	4.92e-06	3.74e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CG—melanoma	4.77e-06	3.62e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CD—melanoma	4.7e-06	3.57e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—melanoma	4.64e-06	3.52e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—melanoma	4.6e-06	3.49e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS1—melanoma	4.56e-06	3.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAP2K1—melanoma	4.55e-06	3.45e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—S100B—melanoma	4.55e-06	3.45e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CD—melanoma	4.52e-06	3.43e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTEN—melanoma	4.5e-06	3.41e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP17A1—melanoma	4.39e-06	3.33e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB4—melanoma	4.35e-06	3.3e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	4.34e-06	3.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN2B—melanoma	4.31e-06	3.27e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CG—melanoma	4.26e-06	3.23e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CD—melanoma	4.19e-06	3.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD86—melanoma	4.17e-06	3.17e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—melanoma	4.17e-06	3.16e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNA11—melanoma	4.14e-06	3.15e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—melanoma	4.14e-06	3.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—melanoma	4.14e-06	3.14e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—melanoma	4.11e-06	3.12e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CB—melanoma	4.1e-06	3.11e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—melanoma	4.06e-06	3.08e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FASN—melanoma	4.05e-06	3.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF1—melanoma	4.04e-06	3.07e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CSF2—melanoma	4.04e-06	3.07e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC5A5—melanoma	3.99e-06	3.03e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—melanoma	3.98e-06	3.02e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CG—melanoma	3.97e-06	3.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—E2F1—melanoma	3.96e-06	3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CB—melanoma	3.94e-06	2.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDGFRA—melanoma	3.92e-06	2.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ITGB3—melanoma	3.88e-06	2.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCA—melanoma	3.88e-06	2.94e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNAQ—melanoma	3.85e-06	2.93e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CD44—melanoma	3.85e-06	2.93e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—melanoma	3.83e-06	2.91e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—melanoma	3.8e-06	2.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAP2K2—melanoma	3.79e-06	2.88e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—melanoma	3.78e-06	2.87e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CD—melanoma	3.74e-06	2.84e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—melanoma	3.7e-06	2.81e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1B1—melanoma	3.69e-06	2.8e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CB—melanoma	3.65e-06	2.77e-05	CbGpPWpGaD
Procainamide—SLC22A5—lymph node—melanoma	3.65e-06	0.0106	CbGeAlD
Procainamide—BCHE—Metabolism—PTGS2—melanoma	3.62e-06	2.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—melanoma	3.62e-06	2.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TERT—melanoma	3.6e-06	2.74e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RAC1—melanoma	3.59e-06	2.73e-05	CbGpPWpGaD
Procainamide—BCHE—lymph node—melanoma	3.56e-06	0.0104	CbGeAlD
Procainamide—ACHE—Metabolism—PTEN—melanoma	3.54e-06	2.69e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CD—melanoma	3.49e-06	2.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HIF1A—melanoma	3.45e-06	2.62e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—melanoma	3.44e-06	2.62e-05	CbGpPWpGaD
Procainamide—CYP2D6—head—melanoma	3.36e-06	0.00981	CbGeAlD
Procainamide—CHRM2—Signaling Pathways—KDR—melanoma	3.3e-06	2.5e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CB—melanoma	3.26e-06	2.48e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—melanoma	3.23e-06	2.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FN1—melanoma	3.17e-06	2.41e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—melanoma	3.17e-06	2.41e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTEN—melanoma	3.16e-06	2.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH1—melanoma	3.1e-06	2.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD80—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CB—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCB1—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APC—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CG—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KIT—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NRAS—melanoma	3.04e-06	2.31e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—melanoma	3.01e-06	2.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGF—melanoma	3e-06	2.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAPK3—melanoma	2.91e-06	2.21e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BRAF—melanoma	2.85e-06	2.17e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTEN—melanoma	2.82e-06	2.14e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PRKCA—melanoma	2.8e-06	2.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—melanoma	2.78e-06	2.11e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ERCC2—melanoma	2.78e-06	2.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAPK1—melanoma	2.77e-06	2.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—melanoma	2.77e-06	2.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAP2K1—melanoma	2.69e-06	2.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CD—melanoma	2.67e-06	2.03e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	2.64e-06	2.01e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTEN—melanoma	2.63e-06	2e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KRAS—melanoma	2.61e-06	1.98e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—melanoma	2.59e-06	1.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF2—melanoma	2.56e-06	1.94e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—melanoma	2.5e-06	1.9e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—melanoma	2.4e-06	1.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MDM2—melanoma	2.39e-06	1.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB2—melanoma	2.36e-06	1.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CB—melanoma	2.33e-06	1.77e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—melanoma	2.24e-06	1.7e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—melanoma	2.23e-06	1.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—melanoma	2.22e-06	1.69e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CG—melanoma	2.19e-06	1.66e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1B—melanoma	2.18e-06	1.66e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—melanoma	2.16e-06	1.64e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—melanoma	2.14e-06	1.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—melanoma	2.14e-06	1.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—melanoma	2.13e-06	1.61e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—melanoma	2.12e-06	1.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—melanoma	2.08e-06	1.58e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—melanoma	2.06e-06	1.57e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—melanoma	2.04e-06	1.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—melanoma	2.02e-06	1.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1A—melanoma	2.01e-06	1.53e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTEN—melanoma	2.01e-06	1.53e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFKB1—melanoma	2e-06	1.52e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—melanoma	1.99e-06	1.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—melanoma	1.96e-06	1.49e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CD—melanoma	1.93e-06	1.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—melanoma	1.9e-06	1.44e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—melanoma	1.85e-06	1.41e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—melanoma	1.82e-06	1.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—melanoma	1.82e-06	1.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—melanoma	1.8e-06	1.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NRAS—melanoma	1.79e-06	1.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK3—melanoma	1.72e-06	1.3e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CB—melanoma	1.68e-06	1.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—melanoma	1.67e-06	1.27e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—melanoma	1.66e-06	1.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK1—melanoma	1.63e-06	1.24e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—melanoma	1.63e-06	1.24e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—melanoma	1.62e-06	1.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KRAS—melanoma	1.54e-06	1.17e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—melanoma	1.51e-06	1.15e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTEN—melanoma	1.45e-06	1.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.42e-06	1.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—melanoma	1.37e-06	1.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—melanoma	1.31e-06	9.96e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—melanoma	1.26e-06	9.54e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—melanoma	1.16e-06	8.8e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—melanoma	1.02e-06	7.78e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—melanoma	8.36e-07	6.35e-06	CbGpPWpGaD
